Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

RegeneRx presents phase II RGN-137 results in venous stasis

March 27, 2009

Advancell collaborates with Nobera to develop hand-foot syndrome treatment

March 27, 2009

NovaBay and Galderma sign global agreement to develop and commercialize Aganocide

March 26, 2009

Torii to launch Remitch in Japan for pruritus in hemodialysis

March 24, 2009

Healthpoint initiates phase II study for cell-based venous leg ulcer therapy

March 17, 2009

Merck KGaA presents novel tyrosinase inhibitors

March 17, 2009

Novel candidates for the treatment of psoriasis display clinical efficacy and safety

March 17, 2009

Renovo reports phase II results for Juvidex

March 16, 2009

BioCis Pharma commences phase IIa testing for ProtoCure in psoriasis

March 16, 2009

Novel skin protease inhibitors may provide new treatment for atopic dermatitis

March 13, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...